Showing 2,676 results

Filters Content type: News, Editors' picks, About HIV Topic: Hepatitis & HIV

Hepatitis A, B and C are viral infections that can damage the liver and cause serious illnesses. Co-infection with HIV and hepatitis B or C is quite common. Safe and effective treatments are available.

Drug interactions & pharmacokinetics

Ritonavir the cause of the interaction between telaprevir and ritonavir-boosted atazanavir

News
25 November 2013
New & experimental hepatitis C treatment

FDA approves new treatment for hepatitis C virus

Editor's pick
US FDA
23 November 2013
New & experimental hepatitis C treatment

European Medicines Agency recommends approval of sofosbuvir for the treatment of chronic hepatitis C

Editor's pick
European Medicines Agency
22 November 2013
New & experimental hepatitis C treatment

Faldaprevir safe and effective in HCV treatment-experienced patients

News
22 November 2013
Treatment guidelines

BHIVA Autumn Conference: Presentations now available online

Editor's pick
British HIV Association
19 November 2013
New & experimental hepatitis C treatment

AbbVie reports 96% cure rate for interferon-free hepatitis C regimen in phase 3 study

News
18 November 2013
New & experimental hepatitis C treatment

AbbVie Releases First of Six Phase III Results from Investigational All-Oral, Interferon-Free, 12-week Regimen, Showing 96 Percent SVR12 in Genotype 1 Hepatitis C Patients New to Therapy

Editor's pick
AbbVie press release
18 November 2013
Hepatitis & HIV

Training manual for treatment advocates: Hepatitis C virus and coinfection with HIV

Editor's pick
TAG
18 November 2013
Hepatitis C treatment

Primary Care Option for Hepatitis C Treatment Cost-Effective

Editor's pick
Medscape (requires registration)
15 November 2013
Hepatitis C treatment

Successful hepatitis C treatment reduces risk of liver cancer and death, but most remain untreated

News
15 November 2013
New & experimental hepatitis C treatment

Sofosbuvir/ribavirin for 24 weeks cures most genotype 3 hepatitis C patients, adding interferon may help difficult-to-treat

News
14 November 2013
Hepatitis C treatment

Costs for Hepatitis C Treatment Skyrocket

Editor's pick
Medscape (requires registration)
14 November 2013
Organ transplants

Congress Votes To End The Outdated Ban On HIV Organ Transplants And Research

Editor's pick
ThinkProgress
13 November 2013
Hepatitis & HIV

Faldaprevir plus pegylated interferon/ribavirin leads to early sustained response in people with HIV and HCV co-infection

News
13 November 2013
Hepatitis C treatment

Daclatasvir + asunaprevir cures 85% of genotype 1b hepatitis C patients in Japanese study

News
12 November 2013
New & experimental hepatitis C treatment

How Much? A Battle Over The Cost Of The New Hepatitis C Drugs

Editor's pick
Pharmalot
12 November 2013
New & experimental hepatitis C treatment

Fixed-dose sofosbuvir/ledipasvir with or without ribavirin cures most genotype 1 hepatitis C patients, LONESTAR study shows

News
11 November 2013
Hepatitis C treatment

Sofosbuvir taken before or after liver transplant reduces hepatitis C recurrence

News
8 November 2013
Hepatitis B

Hepatitis B treatment with entecavir or tenofovir lowers, but does not eliminate, liver cancer risk

News
6 November 2013
New & experimental hepatitis C treatment

Sofosbuvir + ribavirin produces sustained response in 76% of genotype 1 HIV/HCV co-infected people

News
6 November 2013
Hepatitis C treatment

Simeprevir + sofosbuvir produces high sustained response rates for hard-to-treat patients in COSMOS trial

News
5 November 2013
New & experimental hepatitis C treatment

Hepatitis C, a Silent Killer, Meets Its Match

Editor's pick
New York Times
5 November 2013
New & experimental hepatitis C treatment

BMS interferon-free combination cures over 90% of genotype 1 hepatitis C in 12 weeks

News
5 November 2013
New & experimental hepatitis C treatment

Merck interferon-free combination shows high hepatitis C cure rate in early study

News
4 November 2013